659 related articles for article (PubMed ID: 28097901)
1. Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.
Pillaiyar T; Manickam M; Namasivayam V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):403-425. PubMed ID: 28097901
[TBL] [Abstract][Full Text] [Related]
2. Potential adverse effect of tyrosinase inhibitors on teleosts:A review.
Cho K; Ryu CS; Jeong S; Kim Y
Comp Biochem Physiol C Toxicol Pharmacol; 2020 Feb; 228():108655. PubMed ID: 31678677
[TBL] [Abstract][Full Text] [Related]
3. Natural Tyrosinase Inhibitors: Role of Herbals in the Treatment of Hyperpigmentary Disorders.
Zaidi KU; Ali SA; Ali A; Naaz I
Mini Rev Med Chem; 2019; 19(10):796-808. PubMed ID: 31244414
[TBL] [Abstract][Full Text] [Related]
4. The hunt for natural skin whitening agents.
Smit N; Vicanova J; Pavel S
Int J Mol Sci; 2009 Dec; 10(12):5326-5349. PubMed ID: 20054473
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl)acrylonitriles.
Yun HY; Kim DH; Son S; Ullah S; Kim SJ; Kim YJ; Yoo JW; Jung Y; Chun P; Moon HR
Drug Des Devel Ther; 2015; 9():4259-68. PubMed ID: 26347064
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues.
Ullah S; Park C; Ikram M; Kang D; Lee S; Yang J; Park Y; Yoon S; Chun P; Moon HR
Bioorg Chem; 2019 Jun; 87():43-55. PubMed ID: 30856375
[TBL] [Abstract][Full Text] [Related]
9. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
Wang HM; Chen CY; Wen ZH
Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
[TBL] [Abstract][Full Text] [Related]
10. Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation.
Kim HD; Choi H; Abekura F; Park JY; Yang WS; Yang SH; Kim CH
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175965
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anti-melanogenic effect of cinnamamide derivatives.
Ullah S; Park Y; Ikram M; Lee S; Park C; Kang D; Yang J; Akter J; Yoon S; Chun P; Moon HR
Bioorg Med Chem; 2018 Nov; 26(21):5672-5681. PubMed ID: 30366788
[TBL] [Abstract][Full Text] [Related]
12. Acanthoic acid inhibits melanogenesis through tyrosinase downregulation and melanogenic gene expression in B16 melanoma cells.
Yoon WJ; Ham YM; Yoon HS; Lee WJ; Lee NH; Hyun CG
Nat Prod Commun; 2013 Oct; 8(10):1359-62. PubMed ID: 24354173
[TBL] [Abstract][Full Text] [Related]
13. The use of antisense strategy to modulate human melanogenesis.
Lazou K; Sadick NS; Kurfurst R; Bonnet-Duquennoy M; Neveu M; Nizard C; Heusele C; Schnebert S; Perrier E
J Drugs Dermatol; 2007 Jun; 6(6 Suppl):s2-7. PubMed ID: 17691203
[TBL] [Abstract][Full Text] [Related]
14. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
Gillbro JM; Olsson MJ
Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
[TBL] [Abstract][Full Text] [Related]
15. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
[TBL] [Abstract][Full Text] [Related]
16. A novel anti-melanogenic agent, KDZ-001, inhibits tyrosinase enzymatic activity.
Hwang KS; Yang JY; Lee J; Lee YR; Kim SS; Kim GR; Chae JS; Ahn JH; Shin DS; Choi TY; Bae MA
J Dermatol Sci; 2018 Feb; 89(2):165-171. PubMed ID: 29191393
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Alkylhydroquinone from Rhus succedanea as an Inhibitor of Tyrosinase and Melanogenesis.
Chen YR; Y-Y R; Lin TY; Huang CP; Tang WC; Chen ST; Lin SB
J Agric Food Chem; 2009 Mar; 57(6):2200-5. PubMed ID: 19159217
[TBL] [Abstract][Full Text] [Related]
18. Functionality study of santalin as tyrosinase inhibitor: A potential depigmentation agent.
Hridya H; Amrita A; Mohan S; Gopalakrishnan M; Dakshinamurthy TK; Doss GP; Siva R
Int J Biol Macromol; 2016 May; 86():383-9. PubMed ID: 26828288
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
Roulier B; Pérès B; Haudecoeur R
J Med Chem; 2020 Nov; 63(22):13428-13443. PubMed ID: 32787103
[TBL] [Abstract][Full Text] [Related]
20. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies.
Pintus F; Matos MJ; Vilar S; Hripcsak G; Varela C; Uriarte E; Santana L; Borges F; Medda R; Di Petrillo A; Era B; Fais A
Bioorg Med Chem; 2017 Mar; 25(5):1687-1695. PubMed ID: 28189394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
